Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday

MT Newswires Live06-20

Health care stocks were lower pre-bell Thursday as the Health Care Select Sector SPDR Fund (XLV) was down 0.3% and iShares Biotechnology ETF (IBB) was recently declining by 0.3%.

Jazz Pharmaceuticals (JAZZ) was down more than 3% after saying its investigational therapy suvecaltamide did not meet its primary endpoint in a phase 2b trial evaluating its efficacy and safety in adult patients with essential tremor.

PTC Therapeutics (PTCT) was up over 3% after saying the US Food and Drug Administration has lifted the partial clinical hold on its PTC518 program following favorable interim results from the phase 2 PIVOT-HD study in Huntington's disease patients.

Cara Therapeutics (CARA) late Tuesday disclosed plans to explore strategic alternatives and lay off 70% of its workforce after discontinuing work on its difelikefalin drug candidate last week for failing to show clinical benefit in pruritus treatment, a nerve disorder. Cara Therapeutics rose past 8% premarket.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2444211912?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-20 21:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2444211912","market":"nz","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were lower pre-bell Thursday as the Health Care Select Sector SPDR Fund (XLV) was down 0.3% and <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) was recently declining by 0.3%. </p><p>Jazz Pharmaceuticals (JAZZ) was down more than 3% after saying its investigational therapy suvecaltamide did not meet its primary endpoint in a phase 2b trial evaluating its efficacy and safety in adult patients with essential tremor.</p><p>PTC <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (PTCT) was up over 3% after saying the US Food and Drug Administration has lifted the partial clinical hold on its PTC518 program following favorable interim results from the phase 2 PIVOT-HD study in Huntington's disease patients.</p><p>Cara Therapeutics (CARA) late Tuesday disclosed plans to explore strategic alternatives and lay off 70% of its workforce after discontinuing work on its difelikefalin drug candidate last week for failing to show clinical benefit in pruritus treatment, a nerve disorder. Cara Therapeutics rose past 8% premarket.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Lean Lower Pre-Bell Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-20 21:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Health care stocks were lower pre-bell Thursday as the Health Care Select Sector SPDR Fund (XLV) was down 0.3% and iShares Biotechnology ETF (IBB) was recently declining by 0.3%. Jazz Pharmaceuticals ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JAZZ","symbol_name":"爵士制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2444211912","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2444211912","pubTimestamp":1718889297,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were lower pre-bell Thursday as the Health Care Select Sector SPDR Fund  was down 0.3% and iShares Biotechnology ETF  was recently declining by 0.3%. Jazz Pharmaceuticals  was down more than 3% after saying its investigational therapy suvecaltamide did not meet its primary endpoint in a phase 2b trial evaluating its efficacy and safety in adult patients with essential tremor.PTC Therapeutics  was up over 3% after saying the US Food and Drug Administration has lifted the partial clinical hold on its PTC518 program following favorable interim results from the phase 2 PIVOT-HD study in Huntington's disease patients.Cara Therapeutics  late Tuesday disclosed plans to explore strategic alternatives and lay off 70% of its workforce after discontinuing work on its difelikefalin drug candidate last week for failing to show clinical benefit in pruritus treatment, a nerve disorder. Cara Therapeutics rose past 8% premarket.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"JAZZ":"爵士制药","IBB":"生物科技指数ETF-iShares Nasdaq","BK4533":"AQR资本管理(全球第二大对冲基金)","CARA":"Cara Therapeutics, Inc.","BK4007":"制药","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","PTCT":"PTC Therapeutics Inc.","BK4532":"文艺复兴科技持仓","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","XLV":"健康照护类股ETF-SPDR","BK4588":"碎股","BK4585":"ETF&股票定投概念","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4139":"生物科技","BK4581":"高盛持仓"},"translate_title":"行业更新：医疗保健股周四盘前走低","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CARA":0.9,"IBB":0.9,"JAZZ":0.9,"PTCT":0.9,"XLV":0.9},"content_text":"Health care stocks were lower pre-bell Thursday as the Health Care Select Sector SPDR Fund (XLV) was down 0.3% and iShares Biotechnology ETF (IBB) was recently declining by 0.3%. Jazz Pharmaceuticals (JAZZ) was down more than 3% after saying its investigational therapy suvecaltamide did not meet its primary endpoint in a phase 2b trial evaluating its efficacy and safety in adult patients with essential tremor.PTC Therapeutics (PTCT) was up over 3% after saying the US Food and Drug Administration has lifted the partial clinical hold on its PTC518 program following favorable interim results from the phase 2 PIVOT-HD study in Huntington's disease patients.Cara Therapeutics (CARA) late Tuesday disclosed plans to explore strategic alternatives and lay off 70% of its workforce after discontinuing work on its difelikefalin drug candidate last week for failing to show clinical benefit in pruritus treatment, a nerve disorder. Cara Therapeutics rose past 8% premarket.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2444211912"}